• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于MatriXX的辐射野大小与伽马指数通过率之间相关性的研究。

A study on the correlation between radiation field size and gamma index passing rate for MatriXX.

作者信息

Xie Kai, Sun Hongfei, Gao Liugang, Sui Jianfeng, Lin Tao, Ni Xinye

机构信息

Department of Radiation Oncology, Changzhou No. 2 People's Hospital, Nanjing Medical University.

The Center for Medical Physics of Nanjing Medical University, Changzhou, China.

出版信息

Medicine (Baltimore). 2019 Jul;98(30):e16536. doi: 10.1097/MD.0000000000016536.

DOI:10.1097/MD.0000000000016536
PMID:31348271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6709154/
Abstract

This study aimed to analyze the influence of the radiation field size on the passing rate of the treatment planning system using MatriXX if the field irradiated the circuit.Two sets of static fields which were 10 cm and 30 cm in the left-right direction (X), and was 31 cm to 40 cm in gun-target direction (Y) were designed. In these fields, the gantry was 0 and the monitor units were 200 MU. Two plans from an esophagus carcinoma patient with a planning target volume of 86.4 cm and a cervical carcinoma patient with a planning target volume (PTV) of 2094.1 cm were chosen. The passing rates of these plans were gained without and with protecting the circuit area from lead alloys. The gamma analysis was used and the standard was set to 3%/3 mm.The verification passing rate decreased from 95.0% to 69.2% when X was 10 cm while Y increased from 31 cm to 40 cm. With the protection from low melting point lead alloys, the passing rate was from 96.2% to 89.6%. The results of the second set of plans without lead alloys were similar but the passing rate decreased more sharply. The passing rates of the 2 patients were 99.5% and 57.1%. With the protection of the lead alloys, their passing rates were 99.8% and 72.1%, respectively.The results showed that with the increase of the radiation field size in the Y direction, more areas were irradiated in the circuit, and the passing rate gradually decreases and dropped sharply at a certain threshold. After putting lead alloys above the circuit, the passing rate was much better in the static field but was still less than 90% in the second patient volumetric modulated arc therapy (VMAT) because the circuit was irradiate in other directions. In daily QA, we should pay attention to these patients with long size tumor.

摘要

本研究旨在分析当射野照射到电路时,射野大小对使用MatriXX的治疗计划系统通过率的影响。设计了两组静态射野,其左右方向(X)分别为10 cm和30 cm,靶区方向(Y)为31 cm至40 cm。在这些射野中,机架角度为0,监测单位为200 MU。选取了一名计划靶体积为86.4 cm³的食管癌患者和一名计划靶体积(PTV)为2094.1 cm³的宫颈癌患者的两个计划。分别在不保护和保护电路区域免受铅合金影响的情况下获得这些计划的通过率。采用伽马分析,标准设定为3%/3 mm。当X为10 cm且Y从31 cm增加到40 cm时,验证通过率从95.0%降至69.2%。在低熔点铅合金的保护下,通过率从96.2%降至89.6%。第二组无铅合金计划的结果相似,但通过率下降得更急剧。两名患者的通过率分别为99.5%和57.1%。在铅合金的保护下,其通过率分别为99.8%和72.1%。结果表明,随着Y方向射野尺寸的增加,电路中被照射的区域更多,通过率逐渐降低,并在一定阈值处急剧下降。在电路上方放置铅合金后,静态射野中的通过率要好得多,但在第二名患者的容积调强弧形治疗(VMAT)中仍低于90%,因为电路在其他方向受到照射。在日常质量保证中,我们应关注这些肿瘤尺寸较长的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/bcbbc1e74c88/medi-98-e16536-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/d2518a4ae01c/medi-98-e16536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/ff47f689a692/medi-98-e16536-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/b829da8319e0/medi-98-e16536-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/5d32a379e3eb/medi-98-e16536-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/1b870b598ed5/medi-98-e16536-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/bcbbc1e74c88/medi-98-e16536-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/d2518a4ae01c/medi-98-e16536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/ff47f689a692/medi-98-e16536-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/b829da8319e0/medi-98-e16536-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/5d32a379e3eb/medi-98-e16536-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/1b870b598ed5/medi-98-e16536-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/6709154/bcbbc1e74c88/medi-98-e16536-g008.jpg

相似文献

1
A study on the correlation between radiation field size and gamma index passing rate for MatriXX.关于MatriXX的辐射野大小与伽马指数通过率之间相关性的研究。
Medicine (Baltimore). 2019 Jul;98(30):e16536. doi: 10.1097/MD.0000000000016536.
2
Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.容积旋转调强弧形治疗与常规调强适形放疗在食管癌中的比较:一项治疗计划的比较。
World J Gastroenterol. 2012 Oct 7;18(37):5266-75. doi: 10.3748/wjg.v18.i37.5266.
3
Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array.使用二维电离室阵列对与患者相关的 Rapid Arc 治疗计划验证进行质量保证协议的两年经验。
Radiat Oncol. 2011 Feb 22;6:21. doi: 10.1186/1748-717X-6-21.
4
Impact of small MU/segment and dose rate on delivery accuracy of volumetric-modulated arc therapy (VMAT).小 MU/段和剂量率对容积旋转调强放疗(VMAT)递送精度的影响。
J Appl Clin Med Phys. 2016 May 8;17(3):203-210. doi: 10.1120/jacmp.v17i3.6046.
5
Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.容积旋转调强弧形治疗技术在胸段食管癌大靶区中的应用。
J Appl Clin Med Phys. 2013 May 6;14(3):4269. doi: 10.1120/jacmp.v14i3.4269.
6
Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.应用 ArcCHECK 剂量系统进行容积调强弧形治疗(VMAT)交付验证的测量比较和蒙特卡罗分析。
J Appl Clin Med Phys. 2013 May 6;14(2):3929. doi: 10.1120/jacmp.v14i2.3929.
7
Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.在射野剂量分布图上进行纹理分析,以评估容积调强弧形放疗的调制度。
Med Phys. 2014 Nov;41(11):111718. doi: 10.1118/1.4897388.
8
A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.容积调强弧形治疗计划针对特定患者的质量保证的回顾性分析。
Med Dosim. 2014 Winter;39(4):309-13. doi: 10.1016/j.meddos.2014.05.003. Epub 2014 Jun 20.
9
Impact of ovary-sparing treatment planning on plan quality, treatment time and gamma passing rates in intensity-modulated radiotherapy for stage I/II cervical cancer.保留卵巢的治疗计划对Ⅰ/Ⅱ期宫颈癌调强放疗计划质量、治疗时间和伽马通过率的影响。
Medicine (Baltimore). 2023 Dec 15;102(50):e36373. doi: 10.1097/MD.0000000000036373.
10
Statistical analysis of correlation of gamma passing results for two quality assurance phantoms used for patient-specific quality assurance in volumetric modulated arc radiotherapy.两种用于容积调强弧形放疗患者特定质量保证的质量保证体模伽马通过率结果相关性的统计分析。
Med Dosim. 2022;47(4):329-333. doi: 10.1016/j.meddos.2022.06.003. Epub 2022 Jul 16.

本文引用的文献

1
A comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapy.四种调强放射治疗剂量学工具的质量保证比较。
Radiol Oncol. 2015 Aug 21;49(3):307-13. doi: 10.1515/raon-2015-0021. eCollection 2015 Sep.
2
A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.各种商业调强放疗/容积旋转调强放射治疗 QA 系统中的伽马指数分析比较。
Radiother Oncol. 2013 Dec;109(3):370-6. doi: 10.1016/j.radonc.2013.08.048. Epub 2013 Oct 4.
3
Three-dimensional radiochromic film dosimetry for volumetric modulated arc therapy using a spiral water phantom.
使用螺旋水模体的容积调强弧形治疗的三维放射色膜剂量测定。
J Radiat Res. 2013 Nov 1;54(6):1153-9. doi: 10.1093/jrr/rrt059. Epub 2013 May 17.
4
Statistical process control analysis for patient-specific IMRT and VMAT QA.用于个体化调强放疗和容积旋转调强放疗质量保证的统计过程控制分析。
J Radiat Res. 2013 May;54(3):546-52. doi: 10.1093/jrr/rrs112. Epub 2012 Dec 7.
5
Development of a novel quality assurance system based on rolled-up and rolled-out radiochromic films in volumetric modulated arc therapy.基于卷绕和展开放射色胶片的容积调强弧形治疗新型质量保证系统的开发。
Med Phys. 2011 Dec;38(12):6688-96. doi: 10.1118/1.3659706.
6
Quality assurance of RapidArc in clinical practice using portal dosimetry.使用电子射野影像系统进行容积旋转调强弧形治疗的质量保证。
Br J Radiol. 2011 Jun;84(1002):534-45. doi: 10.1259/bjr/72327299.
7
RapidArc quality assurance through MapCHECK.通过 MapCHECK 进行 RapidArc 质量保证。
J Appl Clin Med Phys. 2011 Jan 5;12(2):3251. doi: 10.1120/jacmp.v12i2.3251.
8
Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array.使用二维电离室阵列对与患者相关的 Rapid Arc 治疗计划验证进行质量保证协议的两年经验。
Radiat Oncol. 2011 Feb 22;6:21. doi: 10.1186/1748-717X-6-21.
9
3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetry.通过门控剂量学对容积调强弧形治疗进行三维剂量验证。
Radiother Oncol. 2010 Feb;94(2):181-7. doi: 10.1016/j.radonc.2009.12.020. Epub 2010 Jan 19.
10
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119.调强适形放疗的验证:多机构计划和剂量学比较,AAPM 工作组 119 报告
Med Phys. 2009 Nov;36(11):5359-73. doi: 10.1118/1.3238104.